Back to Market Feed

NORPACE CR 150 MG CAPSULE

disopyramide phosphate
$4.9062per EA
High Outlier

Strength

150 mg/1

Manufacturer

Pfizer Inc.

NDC

00025274231

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

1/1/2025

Active Ingredients

DISOPYRAMIDE PHOSPHATE

Approval Type

New Drug (NDA)

FDA Application

NDA018655

On Market Since

7/20/1982

Pharmacological Classes

Antiarrhythmic

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+8.1%

5Y

+8.1%

All

+90.7%

Generic Alternatives

Save up to 67%

1 alternative • Same active ingredient

DISOPYRAMIDE 150 MG CAPSULE
Generic
59762040001•Mylan Pharmaceuticals Inc.
$1.6372
Save 67%

Related Drugs

Same classification

XYLOCAINE 2%-EPI 1:100,000
Brand
63323048327•Fresenius Kabi USA, LLC
$0.2655
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048226•Fresenius Kabi USA, LLC
$0.2721
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048227•Fresenius Kabi USA, LLC
$0.2721
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053025•Azurity Pharmaceuticals Inc.
$2.3056
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053048•Azurity Pharmaceuticals Inc.
$2.3353
per ML
TIKOSYN 125 MCG CAPSULE
Brand
00069580060•Pfizer Inc.
$9.8598
per EA
TIKOSYN 125 MCG CAPSULE
Brand
00069580061•Pfizer Inc.
$9.8598
per EA
TIKOSYN 250 MCG CAPSULE
Brand
00069581060•Pfizer Inc.
$9.9057
per EA
TIKOSYN 250 MCG CAPSULE
Brand
00069581061•Pfizer Inc.
$9.9057
per EA
TIKOSYN 500 MCG CAPSULE
Brand
00069582060•Pfizer Inc.
$10.7711
per EA